Ayoma T, Hagiwara S, Murase Y, Kato T, Iwata T. Adverse reactions and antibody responses to acellular pertussis vaccine . J Pediatr. 1986;;109:925-930.
American Academy of Pediatrics Committee on Infectious Disease. Acellular pertussis vaccines: recommendations for use as the fourth and fifth doses . Pediatrics . 1992;;90:121-123.
Centers for Disease Control. FDA approval of use of diphtheria and tetanus toxoids and acellular pertussis vaccine . MMWR . 1991;;40:881-882.
Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events . Lancet . 1988;;1:955-960.
Blennow M, Granstrom M. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants . Pediatrics . 1989;;84:62-67.
Gillenius P, Jaatmaa E, Askelof P, Granstrom M, Tiru M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells . J Biol Standardization . 1985;;13:61-66.
Manclark LR, Meade BD, Burstyn DG. Serological response to Bordetella pertussis . In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology . 3rd ed. Washington, DC: American Society for Microbiology; 1986;:388-394.
Craig J P. Immune response to Corynebacterium diphtheria and Clostridium tetani . In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology . 3rd ed. Washington, DC: American Society for Microbiology; 1986;:408-414.
Lewis K, Cherry JD, Holroyd J, Baker LR, Dudenhoeffer FE, Robinson RG. A double-blind study comparing an acellular pertussis-component DTP vaccine with whole-cell pertussis-component DTP vaccine in 18-month-old children . AJDC . 1986;;140:872-876.
Pichichero ME, Budgett JT, Rodgers GC, McLinn S, Trevino-Scatterday B, Nelson JD. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18-to 24-month-old children . Pediatr Infect Dis J. 1987;;6:352-363.
Edwards KM, Lawrence E, Wright PF. Diphtheria, tetanus, and pertussis vaccine: a comparison of the immune response and adverse reactions to conventional and acellular pertussis components . AJDC . 1986;;140:867-871.
Anderson EL, Belshe RB, Bartram J, et al. Clinical and serologic responses to acellular pertussis vaccine in infants and young children . AJDC . 1987;;141:949-953.
Blumberg DA, Mink CM, Cherry JD, et al. Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody . J Pediatr. 1990;;117:46-51.
Tomoda T, Ogura H, Kurashige T. Immune responses to Bordetella pertussis infection and vaccination . J Infect Dis. 1991;;163:559-563.
Edwards KM, Bradley RB, Decker MD, et al. Evaluation of a new highly purified pertussis vaccine in infants and children . J Infect Dis. 1989;;160: 832-837.
Noble GR, Bernier RH, Esber EC, et al. Acellular and whole-cell pertussis vaccines in Japan: report of a visit by US scientists . JAMA . 1987;;257: 1351-1356.
Feldman S, Perry S, Andrew M, et al. Comparison of acellular (B-type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children . J Pediatr. 1992;;121:857-861.
Kovel A, Wald ER, Guerra N, Serdy C, Meschievitz CK. Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites . J Pediatr. 1992;;120:84-87.
Edwards KM, Decker MD, Bradley RB, Taylor JC, Hager CC. Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines . Pediatr Infect Dis J. 1991;;10:315-318.
Bernstein HH, Rothstein EP, Pichichero ME, et al. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children . AJDC . 1992;; 146:556-559.
Edwards KM, Decker MD, Halsey NA, et al. Differences in antibody response to whole-cell pertussis vaccines . Pediatrics . 1991;;88:1019-1023.
Storsaeter J, Blackwelder WC, Hallander HO. Pertussis antibodies, protection, and vaccine efficacy after household exposure . AJDC . 1992;;146: 167-172.
Aoyama T, Murase Y, Gonda T, Iwata T. Type-specific efficacy of acellular pertussis vaccine . AJDC . 1988;;142:40-42.
Aoyama T, Murase Y, Kato M, Iwai H, Iwata T. Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age . AJDC . 1989;;143:655-659.